Viking Global, led by Andreas Halvorsen, liquidated its entire position in HCA Healthcare during the second quarter of 2026. According to a quarterly disclosure filed with the SEC on August 14, the firm sold its 1.08 million shares, a stake previously valued at over $500 million. This transaction was part of a series of notable second-quarter exits for the investment firm.
The sale occurred during a period of mixed financial results for HCA Healthcare. The hospital operator reported an 8.7% increase in revenue for the second quarter. However, the company also faced challenges, including a decline in operating cash flow and a negative impact on pre-tax income from a shift in payer mix due to a rise in uninsured patients. Investors are reminded that 13F filings reflect trades made in the prior quarter.